Nico van Zandwijk
Nico van Zandwijk
Professor Emeritus University of Sydney
Verified email at sydney.edu.au
TitleCited byYear
Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer
C Schaake-Koning, W Van den Bogaert, O Dalesio, J Festen, ...
New England Journal of Medicine 326 (8), 524-530, 1992
14981992
K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung
RJC Slebos, RE Kibbelaar, O Dalesio, A Kooistra, J Stam, CJLM Meijer, ...
New England Journal of Medicine 323 (9), 561-565, 1990
8621990
Mutational activation of the K-ras oncogene
S Rodenhuis, ML van de Wetering, WJ Mooi, SG Evers, N van Zandwijk, ...
New England Journal of Medicine 317 (15), 929-935, 1987
5821987
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non–small-cell lung cancer
JP Van Meerbeeck, GWPM Kramer, PEY Van Schil, C Legrand, EF Smit, ...
Journal of the National Cancer Institute 99 (6), 442-450, 2007
5762007
Circulating microRNAs: Association with disease and potential use as biomarkers
G Reid, MB Kirschner, N van Zandwijk
Critical reviews in oncology/hematology 80 (2), 193-208, 2011
4452011
EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer
N Van Zandwijk, O Dalesio, U Pastorino, N De Vries, H Van Tinteren
Journal of the National Cancer Institute 92 (12), 977-986, 2000
4102000
Haemolysis during sample preparation alters microRNA content of plasma
MB Kirschner, SC Kao, JJ Edelman, NJ Armstrong, MP Vallely, ...
PloS one 6 (9), 2011
3872011
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
T Le Chevalier, G Scagliotti, R Natale, S Danson, R Rosell, R Stahel, ...
Lung cancer 47 (1), 69-80, 2005
3692005
Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer
U Gatzemeier, G Groth, C Butts, N Van Zandwijk, F Shepherd, A Ardizzoni, ...
Annals of oncology 15 (1), 19-27, 2004
3452004
Photodynamic therapy: a promising new modality for the treatment of cancer
JJ Schuitmaker, P Baas, H Van Leengoed, FW Van der Meulen, WM Star, ...
Journal of Photochemistry and Photobiology B: Biology 34 (1), 3-12, 1996
3171996
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment …
G Giaccone, TA Splinter, C Debruyne, GS Kho, P Lianes, N Van Zandwijk, ...
Journal of clinical oncology 16 (6), 2133-2141, 1998
3051998
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer
CJ Hoekstra, SG Stroobants, EF Smit, J Vansteenkiste, H van Tinteren, ...
J Clin Oncol 23 (33), 8362-70, 2005
2942005
Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers
CAL Ruivenkamp, T van Wezel, C Zanon, APM Stassen, C Vlcek, ...
Nature genetics 31 (3), 295-300, 2002
2692002
High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy
SCH Kao, N Pavlakis, R Harvie, JL Vardy, MJ Boyer, N van Zandwijk, ...
Clinical cancer research 16 (23), 5805-5813, 2010
2582010
Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer …
G Giaccone, A Ardizzoni, A Kirkpatrick, M Clerico, T Sahmoud, ...
Journal of clinical oncology 14 (3), 814-820, 1996
2181996
Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre.
MT Huizing, G Giaccone, LJ Van Warmerdam, H Rosing, PJ Bakker, ...
Journal of clinical oncology 15 (1), 317-329, 1997
2011997
The impact of hemolysis on cell-free microRNA biomarkers
MB Kirschner, JJB Edelman, SCH Kao, MP Vallely, N Van Zandwijk, ...
Frontiers in genetics 4, 94, 2013
1922013
GEMCITABINE AND CISPLATIN AS INDUCTION REGIMEN FOR PATIENTS WITH BIOPSY-PROVEN STAGE IIIA N2 NON-SMALL-CELL LUNG CANCER: A PHASE II STUDY OF THE EUROPEAN ORGANIZATION FOR …
N Van Zandwijk, EF Smit, GWP Kramer, F Schramel, S Gans, J Festen, ...
Radiotherapy in Non-Small-Cell Lung Cancer Changing perspectives in …, 2000
1912000
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel
C Gridelli, A Ardizzoni, T Le Chevalier, C Manegold, F Perrone, ...
Annals of oncology 15 (3), 419-426, 2004
1812004
Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative …
G Giaccone, O Dalesio, GJ McVie, A Kirkpatrick, PE Postmus, ...
Journal of clinical oncology 11 (7), 1230-1240, 1993
1791993
The system can't perform the operation now. Try again later.
Articles 1–20